• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Taking New Medications: Consumers Blame Anxiety on Lack of Time with Physicians

by Jasmine Pennic 01/25/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Taking New Medications: Consumers Blame Anxiety on Lack of Time with Physicians

More than half of consumers lack confidence in their ability to properly take new medications as directed, according to a survey released by DrFirst, the nation’s leading provider of e-prescribing and patient medication management solutions. Among the consumers who had concerns about taking new medications correctly, two-thirds blamed their anxiety on a lack of time with physicians at the point of care.

Survey Background

The online survey of 200 consumers was 40 percent male and 60 percent female focused on patients with non-chronic conditions, also found that the least preferred format for educational information on medications is written materials. Overall, respondents would most prefer learning about a drug’s purpose and potential side effects from a short online video sent by their doctor or pharmacist via a link.

“At a time when most physicians are working at full capacity and have less time for face-to-face patient encounters, it’s critical that we seek alternative methods for educating patients about how to safely take new medications and about each drug’s potential side effects,” said G. Cameron Deemer, president of DrFirst. “Rather than rely on written hand-outs from doctors and pharmacists, we must take advantage of technologies like smartphones and patient portals to deliver impactful, customized details about prescribed medications.”

Other key findings of the survey include: 

– Most consumers are interested in reducing their out-of-pocket costs for prescription medications. That’s not surprising given that recently released analysis from the Office of the Actuary at CMS found that spending for retail prescription drugs reached $333.4 billion in 2017 – and that those rising costs represent 10 percent of overall healthcare spend.

– More than three-quarters of respondents reported trying to obtain coupons or drug discounts for a new prescription, either online or by asking their doctor or pharmacist. Further, 64 percent of consumers would take advantage of an opportunity to pre-pay for out-of-pocket prescription costs in order to receive a discounted price. These new findings are consistent with a previous DrFirst survey which revealed that 73 percent of consumers would change pharmacies if they knew it would save them money on a prescription.

– 67 percent of patients who failed to fill their prescriptions in the last 90 days reported high costs as the reason. These combined findings indicate that giving patients an option for coupons, discounts, or lower-priced pharmacies could drive medication adherence, reduce prescription abandonment and improve health outcomes.

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: DrFirst Interoperability, Medication Adherence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |